IndiaNivesh (501700)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Reported sales growth of 262.75% and profit growth of 156.34% show rapid recent expansion.
• Latest quarter is profitable with ₹2 crore net profit on ₹2 crore sales.
• Reported ROE of 16.77% is respectable for a small NBFC.
• Piotroski F-Score of 7/9 suggests improving financial health across profitability, leverage, and efficiency.
• Price near the 52-week high of ₹14.98 indicates strong current market interest.

Concerns

• Critical data are missing: no book value, no P/B, no debt/equity, no promoter holding, making valuation and governance impossible to assess.
• ROCE of only 4.63% is weak for an NBFC that must deploy capital to earn returns.
• Absolute scale is tiny: latest quarter sales are just ₹2 crore against a ₹58 crore market cap.
• Zero dividend yield and a 100% latest-quarter net margin raise doubts about sustainability and shareholder returns.

AI Analysis

At ₹14.98, IndiaNivesh has a market cap of only ₹58 crore. That is a microcap, and in Graham's world a microcap demands even more transparency, not less. The latest quarter shows ₹2 crore of sales and ₹2 crore of net profit. A 100% net margin is a red flag for any lender — no NBFC can sustain that. The reported 262.75% sales growth and 156.34% profit growth sound impressive, but they come from an extremely small base; one ₹2 crore quarter does not create an enduring franchise. ROE of 16.77% looks acceptable, yet ROCE is just 4.63%. For a non-banking finance company, which earns by deploying capital, such a low return on capital signals weak pricing power, high costs, or an early-stage book. The Piotroski F-Score of 7/9 is encouraging and suggests recent improvements in profitability and balance-sheet mechanics. But the score is no substitute for understanding the loan portfolio. I have no book value, no debt-equity ratio, no promoter holding, and no meaningful dividend. P/E is shown as 0.00 and P/B as N/A. I cannot value what is not disclosed. Without a margin of safety, the rising price from ₹6.05 to ₹14.98 tells me more about market enthusiasm than underlying worth. This may be a fast grower on paper, but it is not a compounder I trust. I would require years of consistent profits, clarity on asset quality, and simple numbers I can verify. Until then, it is a pass.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer